Palivizumab

Therapeutic Palivizumab antibody from the original Synagis® commercial drug

Showing all 6 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
Filters Sort results
Product
Antigen
Molecular Class
Drug Brand
Product Concentration
Volume per Vial
Quantity per vial
Storage Temperature
Expiry Date
Price
Respiratory syncytial virus (RSV)
Monoclonal Antibody
Synagis®
100 mg/mL
40 µL
4 mg
-80°C
04/2019
477,00 
view product
Max: 10
Min: 1
Step: 1
Respiratory syncytial virus (RSV)
Monoclonal Antibody
Synagis®
100 mg/mL
40 µL
4 mg
-80°C
06/2019
477,00 
view product
Max: 10
Min: 1
Step: 1
Respiratory syncytial virus (RSV)
Monoclonal Antibody
Synagis®
100 mg/mL
40 µL
4 mg
-80°C
10/2019
477,00 
view product
Max: 10
Min: 1
Step: 1
Respiratory syncytial virus (RSV)
Monoclonal Antibody
Synagis®
100 mg/mL
40 µL
4 mg
-80°C
02/2020
477,00 
view product
Max: 10
Min: 1
Step: 1
Respiratory syncytial virus (RSV)
Monoclonal Antibody
Synagis®
100 mg/mL
40 µL
4 mg
-80°C
08/2020
477,00 
view product
Max: 10
Min: 1
Step: 1
Respiratory syncytial virus (RSV)
Monoclonal Antibody
Synagis®
100 mg/mL
40 µL
4 mg
2-8°C / -80°C
03/2022
477,00 
view product
Max: 10
Min: 1
Step: 1

Not looking for Palivizumab?

Search our therapeutic molecules product database

Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.